iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 2439

Identifiers

  • Canonical SMILES:
    F[C@H]1CNC[C@H]1Oc1ccc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12
  • IUPAC name:
    1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione
  • InChi:
    InChI=1S/C22H19ClFN3O3S/c23-12-1-2-18(30-19-10-25-9-16(19)24)15(7-12)14-5-6-26-17-8-13(31-22(14)17)11-27-20(28)3-4-21(27)29/h1-2,5-8,16,19,25H,3-4,9-11H2/t16-,19+/m0/s1
  • InChiKey:
    JJPFTAGLDCWDFZ-QFBILLFUSA-N

External links


138610279

CHEMBL4647687

R3Y

External search

Bibliography (1)

Publication Name
Leger Paul R., Hu Dennis X., Biannic Berenger, Bui Minna, Han Xinping, Karbarz Emily, Maung Jack, Okano Akinori, Osipov Maksim, Shibuya Grant M., Young Kyle, Higgs Christopher, Abraham Betty, Bradford Delia, Cho Cynthia, Colas Christophe, Jacobson Scott, Ohol Yamini M., Pookot Deepa, Rana Payal, Sanchez Jerick, Shah Niket, Sun Michael, Wong Steve, Brockstedt Dirk G., Kassner Paul D., Schwarz Jacob B., Wustrow David J.. . Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity Journal of Medicinal Chemistry. 22

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
USP7 / Ubiquitin 6.68 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 459.08 g/mol
HBA 6
HBD 1
HBA + HBD 7
AlogP 3.01
TPSA 76.11
RB 5
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
10.1021/acs.jmedchem.0c00245 22 UBP7
Q93009
UBB
P0CG47
Biochemical assay Fluorescence Polarization pIC50 (half maximal inhibitory concentration, -log10) 6.68
Ta Structure Name Drugbank ID
0.4781 PF-00356231 DB03367
0.4651 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE DB07605
0.4448 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide DB06969
0.4330 Sitravatinib DB15036
0.4286 N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE DB08031
0.4251 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine DB06848
0.4178 Glesatinib DB06302
0.4167 PF-06650833 DB15143
0.4156 (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid DB07189
0.4120 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE DB07006
0.4096 RPR131247 DB02744
0.4064 MAX-40279 DB15191
0.4024 (2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID DB07200
0.4023 CRS-3123 DB12262
0.3977 THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE DB07261